Teledyne Technologies heads into its July 22 earnings with options positioning turning measurably more defensive — even as the stock quietly grinds higher.
The clearest signal this week is in the options market. The put/call ratio has climbed to 0.74, well above its 20-day average of 0.56 and nearly 1.8 standard deviations from the mean. That's not a panic reading — the 52-week high is 0.84 — but the shift is notable. The ratio ran below 0.50 through most of late May and early June, meaning the rotation toward puts has happened quickly, compressing into roughly the last week of trading. The stock itself closed at $630.07, up 1.7% on the week and 2.2% on the month, so the defensive hedging isn't a response to price weakness. Investors are buying downside protection into a rally.
Short interest tells a quieter story, but one worth watching. Bears have added modestly — SI has risen about 5.4% over the past week and nearly 10% over the past month, reaching 3.4% of free float. That's not an elevated absolute level, but the direction is consistent and has been building since early May. Borrow conditions remain almost entirely frictionless: cost to borrow is just 0.42% and has actually eased 18% this week, while availability is over 1,900% — meaning the lending pool dwarfs current short interest by nearly 20 times. There is no squeeze pressure here. The modest short buildup looks like measured hedging rather than a conviction short thesis.
The Street picture is mixed but tilting cautious on valuation. Analyst coverage last updated in early May shows a split between bulls and neutral holders. Stifel and Needham both raised targets after Q1 results — to $750 and $735 respectively — and kept Buy ratings, citing record sales, expanding defense margins, and a strong pipeline in underwater drone technology. On the other side, Barclays and Morgan Stanley maintain Equal-Weight ratings, with Barclays at $614 and Morgan Stanley at $680 — both well below where active money has been willing to pay. The consensus target sits around $729, implying about 16% upside from current levels. The P/E has expanded to roughly 25x, up about 1.1 turns over the past week, while EV/EBITDA is near 18.8x. Bulls point to a five-year EBIT CAGR running around 15-16% as justification; bears flag compressed ROCE and modest organic growth as the limiting factors. The ORTEX short score sits at 39.6, a mid-range reading that has drifted gently higher over the past two weeks without signaling any acute stress.
Institutional ownership adds a constructive underpinning. T. Rowe Price recently added over 600,000 shares, bringing their stake to 7.8% of the company — a meaningful new position built through May. JP Morgan Asset Management added around 263,000 shares. BlackRock also nudged higher. These aren't panic-driven flows in either direction; they suggest large allocators are treating the stock as a long-term defense-tech holding rather than a trade. Insider activity from earlier in the year — primarily sales by the Non-Executive Vice Chairman and the Executive Chairman in January and February — was routine in size and has since gone quiet.
Looking ahead, the Q1 print in April delivered a modest +1.4% next-day move before fading to -1.9% over five days, a pattern worth keeping in mind as July 22 approaches. The put/call elevation and the steady short rebuild suggest the question going into Q2 results is less whether Teledyne can sustain record margins and more whether defense-segment growth is accelerating enough to justify multiples that are running at a premium to some of its largest peers — and how the company's M&A appetite is affecting the balance sheet.
See the live data behind this article on ORTEX.
Open TDY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
